BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 24344025)

  • 1. Experience with intensity-modulated radiotherapy in the treatment of head and neck cancer.
    Vanasek J; Odrazka K; Dusek L; Jarkovsky J; Michalek R; Chrobok V; Dolezel M; Kolarova I
    J BUON; 2013; 18(4):970-6. PubMed ID: 24344025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing 3DCRT and inversely optimized IMRT planning for head and neck cancer: equivalence between step-and-shoot and sliding window techniques.
    Longobardi B; De Martin E; Fiorino C; Dell'oca I; Broggi S; Cattaneo GM; Calandrino R
    Radiother Oncol; 2005 Nov; 77(2):148-56. PubMed ID: 16260056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
    Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Submandibular gland-sparing intensity modulated radiotherapy in the treatment of head and neck cancer: sites of locoregional relapse and survival.
    Collan J; Kapanen M; Mäkitie A; Nyman H; Joensuu H; Tenhunen M; Saarilahti K
    Acta Oncol; 2012 Jul; 51(6):735-42. PubMed ID: 22150115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [SIB-IMRT radiotherapy given concomitantly with cisplatin for locally advanced squamous cell head and neck cancer (SCHNC). Evaluation of the early results and toxicity].
    Kiprian D; Jarząbski A; Pawłowska B; Michalski W; Kawecki A
    Otolaryngol Pol; 2011 Sep; 65(5 Suppl):117-25. PubMed ID: 22000261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IMRT using simultaneously integrated boost (SIB) in head and neck cancer patients.
    Studer G; Huguenin PU; Davis JB; Kunz G; Lütolf UM; Glanzmann C
    Radiat Oncol; 2006 Mar; 1():7. PubMed ID: 16722599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience.
    Kam MK; Teo PM; Chau RM; Cheung KY; Choi PH; Kwan WH; Leung SF; Zee B; Chan AT
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1440-50. PubMed ID: 15590175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical response and tumor control based on long-term follow-up and patient-reported outcomes in patients with chemodectomas of the skull base and head and neck region treated with highly conformal radiation therapy.
    Combs SE; Salehi-Allameh B; Habermehl D; Kessel KA; Welzel T; Debus J
    Head Neck; 2014 Jan; 36(1):22-7. PubMed ID: 23649985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience.
    de Arruda FF; Puri DR; Zhung J; Narayana A; Wolden S; Hunt M; Stambuk H; Pfister D; Kraus D; Shaha A; Shah J; Lee NY
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):363-73. PubMed ID: 15925451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cervical lymph node metastases from unknown primary cancer: a single-institution experience with intensity-modulated radiotherapy.
    Villeneuve H; Després P; Fortin B; Filion E; Donath D; Soulières D; Guertin L; Ayad T; Christopoulos A; Nguyen-Tan PF
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1866-71. PubMed ID: 21497452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteoradionecrosis of the mandible: minimized risk profile following intensity-modulated radiation therapy (IMRT).
    Studer G; Studer SP; Zwahlen RA; Huguenin P; Grätz KW; Lütolf UM; Glanzmann C
    Strahlenther Onkol; 2006 May; 182(5):283-8. PubMed ID: 16673062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic intensity-modulated non-coplanar arc radiotherapy (INCA) for head and neck cancer.
    Krayenbuehl J; Davis JB; Ciernik IF
    Radiother Oncol; 2006 Nov; 81(2):151-7. PubMed ID: 17055095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of patients with head-and-neck cancer of unknown primary origin treated with intensity-modulated radiotherapy.
    Shoushtari A; Saylor D; Kerr KL; Sheng K; Thomas C; Jameson M; Reibel J; Shonka D; Levine P; Read P
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e83-91. PubMed ID: 21377283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma.
    Lu TX; Mai WY; Teh BS; Zhao C; Han F; Huang Y; Deng XW; Lu LX; Huang SM; Zeng ZF; Lin CG; Lu HH; Chiu JK; Carpenter LS; Grant WH; Woo SY; Cui NJ; Butler EB
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):682-7. PubMed ID: 14967420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potential of intensity-modulated proton radiotherapy to reduce swallowing dysfunction in the treatment of head and neck cancer: A planning comparative study.
    van der Laan HP; van de Water TA; van Herpt HE; Christianen ME; Bijl HP; Korevaar EW; Rasch CR; van 't Veld AA; van der Schaaf A; Schilstra C; Langendijk JA;
    Acta Oncol; 2013 Apr; 52(3):561-9. PubMed ID: 22708528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensity-modulated radiotherapy with concurrent chemotherapy for previously irradiated, recurrent head and neck cancer.
    Biagioli MC; Harvey M; Roman E; Raez LE; Wolfson AH; Mutyala S; Han HS; Markoe A
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1067-73. PubMed ID: 17967302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensity-modulated radiotherapy in head and neck cancer: results of the prospective study GORTEC 2004-03.
    Toledano I; Graff P; Serre A; Boisselier P; Bensadoun RJ; Ortholan C; Pommier P; Racadot S; Calais G; Alfonsi M; Favrel V; Giraud P; Lapeyre M
    Radiother Oncol; 2012 Apr; 103(1):57-62. PubMed ID: 22296746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distant metastases in head-and-neck squamous cell carcinoma treated with intensity-modulated radiotherapy.
    Yao M; Lu M; Savvides PS; Rezaee R; Zender CA; Lavertu P; Buatti JM; Machtay M
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):684-9. PubMed ID: 22169673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and toxicity of reirradiation using intensity-modulated radiotherapy for recurrent or second primary head and neck cancer.
    Sher DJ; Haddad RI; Norris CM; Posner MR; Wirth LJ; Goguen LA; Annino D; Balboni T; Allen A; Tishler RB
    Cancer; 2010 Oct; 116(20):4761-8. PubMed ID: 20572036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.